Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular degeneration, has announced that the companys leading drug candidate, POT-4, has shown early positive safety results in its Phase I study.
The eyes have it for vitamin Vitamins and macular degeneration. September 30th, 2008 by mannunni29 Updated Miss elizabeth learn to keep eye on vision health. S disease, according to a Food and Drug Administration analysis published yesterday in. These fats also offer significant protection against both early and late age related macular degeneration. The eyes have it for vitamin supplements. At least killed in Indian temple stampede. Macular degeneration occurs when the deepest retina zone is
VEGF Trap-Eye can achieve durable improvements in visual acuity and in biologic measurement parameters in the formation of new blood vessels in the treatment of age-related macular degeneration (AMG). This was shown in the final evaluation of a Phase 2 study presented at the annual meeting of the Retina Society in Scottsdale, Arizona.
NeoVista, Inc. made public yesterday 18-month data from the company’s Phase II feasibility study examining its novel epiretinal brachytherapy for treatment of the wet form of age-related macular degeneration (AMD) at the 41st Scientific Meeting of the Retina Society.
Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD) announced that the Company’s leading drug candidate, POT-4, has shown early positive safety results in its Phase I study.
